Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Squamous Cell Carcinoma of Head and Neck 37Head and Neck Neoplasms 28Prostatic Neoplasms 16Oropharyngeal Neoplasms 11Carcinoma, Non-Small-Cell Lung 10Uterine Cervical Neoplasms 8Gliosarcoma 8Glioblastoma 8Carcinoma, Squamous Cell 7Brain Neoplasms 7Tongue Neoplasms 6Rectal Neoplasms 6Pancreatic Neoplasms 5Lung Neoplasms 5Laryngeal Neoplasms 5Astrocytoma 5Papillomavirus Infections 4Neoplasm Metastasis 4Mouth Neoplasms 4Sarcoma 3Neoplasms 3Hypopharyngeal Neoplasms 3Glioma 3Carcinoma 3Breast Neoplasms 3Urinary Bladder Neoplasms 2Thyroid Carcinoma, Anaplastic 2Stomatitis 2Rhabdomyosarcoma 2Radiation Injuries 2

Interventions

Gemcitabine 13Cisplatin 8Capecitabine 8Fluorouracil 5pembrolizumab 4Oxaliplatin 4Sorafenib 3Leucovorin 3Erlotinib Hydrochloride 3trametinib 2regorafenib 2durvalumab 2N-(3-chloro-4-((3-fluorobenzyl)oxy)phenyl-6-(5-((methylsulfonyl)ethyl)aminomethyl)-2-furyl)-4-quinazolinamine 2Magnetic Resonance Spectroscopy 2Lapatinib 2trifluridine tipiracil drug combination 1tremelimumab 1spartalizumab 1seribantumab 1olutasidenib 1olaparib 1devimistat 1derazantinib 1dehydroftorafur 1cediranib 1cabozantinib 1Trifluridine 1Trastuzumab 1Therapeutics 1Sutures 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Bile Duct Neoplasms × Radiotherapy, Intensity-Modulated × Clear all
NCT00789958 2018-04-09

S0809: Capecitabine, Gemcitabine, and RT in Patients w/Cholangiocarcinoma of the Gallbladder or Bile Duct

SWOG Cancer Research Network

Phase 2 Completed
105 enrolled 13 charts
Gastrointestinal

Bile Duct Neoplasms, Gallbladder Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡